Fixed-dose combination tablets integrating biguanide and alpha-glucosidase inhibitor for type 2 diabetes management. Pharmaceutical manufacturers supply to wholesalers, hospitals, clinics, and pharmacies for procurement by endocrinologists and primary care providers in outpatient and institutional settings.